24/7 Patient Assistance: 760-405-8205

Adil Daud, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

Hospitals & Clinics

  • Bio & Insurance Information

    Dr. Adil Daud graduated the medical school from the Government Medical College Nagpur and completed his residency program at the Indiana University School of Medicine. A fellowship at the Memorial Sloan-Kettering Cancer Center followed soon after that. Dr. Daud is specialized in oncology and board certified in internal medicine and medical oncology. He has been in practice for more than 20 years and is affiliated with the UCSF Medical Center. During his career, he has also contributed to several publications of medical interest.

  • Education & Training


    Government Medical College Nagpur

    Medical School


    Indiana University School of Medicine



    Memorial Sloan-Kettering Cancer Center


  • Board Certifications

    American Board of Internal Medicine

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    UCSF Medical Center

    Languages: English/Spanish

    (415) 353-1037

    505 Parnassus Ave

    San Francisco, California 94143

    Read More
  • Publications & Memberships

    Dr. Adil Daud has contributed to 3 publications.

    Phase I Dose-Escalation Trial of Checkpoint Kinase 1 Inhibitor MK-8776 As Monotherapy and in Combination With Gemcitabine in Patients With Advanced Solid Tumors.

    Daud, A. I.,Ashworth, M. T.,Strosberg, J.,Goldman, J. W.,Mendelson, D.,Springett, G.,Venook, A. P.,Loechner, S.,Rosen, L. S.,Shanahan, F.,Parry, D.,Shumway, S.,Grabows...; J. Clin. Oncol.. 2015 Jan 22.

    See more >>

    Combination of vemurafenib and cobimetinib in patients with advanced BRAF(V600)-mutated melanoma: a phase 1b study.

    Ribas, A.,Gonzalez, R.,Pavlick, A.,Hamid, O.,Gajewski, T. F.,Daud, A.,Flaherty, L.,Logan, T.,Chmielowski, B.,Lewis, K.,Kee, D.,Boasberg, P.,Yin, M.,Chan, I.,Musib, L.,...; Lancet Oncol.. 2014 Jul 20.

    See more >>

    Involution of Eruptive Melanocytic Nevi on Combination BRAF and MEK Inhibitor Therapy.

    Chen, F. W.,Tseng, D.,Reddy, S.,Daud, A. I.,Swetter, S. M.; JAMA Dermatol. 2014 Aug 22.

    See more >>


    American Association for Cancer Research